This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Humanitas Mirasole S.p.a.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Luigi Laghi: Innovator in Cancer Diagnosis
Introduction
Luigi Laghi is a prominent inventor based in Rozzano, Italy. He has made significant contributions to the field of cancer diagnosis, particularly focusing on colorectal and pancreatic cancers. His innovative approach combines molecular biology with clinical applications, aiming to improve patient outcomes through early detection.
Latest Patents
Laghi holds a patent for a method that determines if a subject is affected by colorectal or pancreatic cancer. This method involves measuring the presence of a panel of mRNAs encoding transcription factors and genes involved in epithelial to mesenchymal transition in blood samples. The different mRNA levels of genes such as TWIST1, SLUG, ZEB2, ZEB1, and CDH1 serve as indicators for cancer diagnosis and progression. This invention also includes the use of kits designed to facilitate the method.
Career Highlights
Laghi is associated with Humanitas Mirasole S.p.a., where he applies his expertise in cancer research and diagnostics. His work has been instrumental in advancing methodologies that enhance the accuracy of cancer detection and staging. His dedication to improving diagnostic techniques has positioned him as a key figure in the medical research community.
Collaborations
Laghi collaborates with Giuseppe Celesti, contributing to the development of innovative solutions in cancer diagnostics. Their partnership exemplifies the importance of teamwork in advancing medical research and technology.
Conclusion
Luigi Laghi's contributions to cancer diagnosis through his patented methods highlight the critical role of innovation in healthcare. His work not only aids in early detection but also enhances the understanding of cancer progression, ultimately benefiting patients worldwide.